FORMELA JEAN FRANCOIS
Director
3 filings on record here, covering KRRO. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-13
| Sell | KRRO | Korro Bio, Inc. | $24,779 |
| Sell | KRRO | Korro Bio, Inc. | $5,137 |
CORPORATEFiled 2026-07-07
| Sell | KRRO | Korro Bio, Inc. | $1,205,949 |
| Sell | KRRO | Korro Bio, Inc. | $206,872 |
| Sell | KRRO | Korro Bio, Inc. | $11,405 |
| Sell | KRRO | Korro Bio, Inc. | $118,744 |
CORPORATEFiled 2026-06-24
| Sell | KRRO | Korro Bio, Inc. | $47,179 |
| Sell | KRRO | Korro Bio, Inc. | $8,091 |
| Sell | KRRO | Korro Bio, Inc. | $1,447,501 |
| Sell | KRRO | Korro Bio, Inc. | $248,320 |
| Sell | KRRO | Korro Bio, Inc. | $593,913 |
| Sell | KRRO | Korro Bio, Inc. | $9,977 |
| Sell | KRRO | Korro Bio, Inc. | $101,893 |
| Sell | KRRO | Korro Bio, Inc. | $1,708 |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.